Inhibition of Tumor Cell Growth by the Lymphokine Sirs - H Schnaper

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Research Project (R01)
Project #: 1R01CA040567-01
Application #: 3180697
Study Section: Experimental Immunology Study Section (EI)

Project Start: 1986-02-01
Project End: 1989-01-31
Budget Start: 1986-02-01
Budget End: 1987-01-31
Support Year: 1
Fiscal Year: 1986
Total Cost
Indirect Cost

Institution

Name: Barnes-Jewish Hospital
Department
Type
DUNS #

City: Saint Louis
State: MO
Country: United States
Zip Code: 63110

Related projects


NIH 1988 R01 CA	Inhibition of Tumor Cell Growth by the Lymphokine Sirs Schnaper, H William / Washington University
NIH 1987 R01 CA	Inhibition of Tumor Cell Growth by the Lymphokine Sirs Schnaper, H William / Barnes-Jewish Hospital
NIH 1986 R01 CA	Inhibition of Tumor Cell Growth by the Lymphokine Sirs Schnaper, H William / Barnes-Jewish Hospital

Publications

Schnaper, H W (1990) A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome. Kidney Int 38:151-9

Schnaper, H W (1989) Divalent metal requirement for soluble immune response suppressor (SIRS) activity. Cell Immunol 118:157-65

Schnaper, H W; Aune, T M; Roby, R K (1987) A role for histamine type II (H-2) receptor binding in production of the lymphokine, soluble immune response suppressor (SIRS). J Immunol 139:1185-90

Comments

Be the first to comment on this grant